Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Di-p-toluoyl-d-tartaric Acid
2. Di-p-toluoyltartaric Acid
1. 32634-68-7
2. Di-p-toluoyl-d-tartaric Acid
3. (+)-di-1,4-toluoyl-d-tartaric Acid
4. (2s,3s)-2,3-bis((4-methylbenzoyl)oxy)succinic Acid
5. (+)-o,o'-di-p-toluoyl-d-tartaric Acid
6. Ditoluoyltartaric Acid, (+)-
7. (2s,3s)-2,3-bis[(4-methylbenzoyl)oxy]butanedioic Acid
8. (+)-dtta
9. Mfcd00008552
10. (+)-ditoluoyltartaric Acid
11. (2s,3s)-2,3-bis[(4-methylbenzoyl)oxy]succinic Acid
12. 4480ma5qip
13. (+)-di-p-toluoyl-d-tartaric Acid
14. Di-p-toluoyl-l-tartaric Acid
15. Nsc-97592
16. (+)-di-(p-toluoyl)-d-tartaric Acid
17. (+)-di-o-p-toluoyl-d-tartaric Acid
18. [s(r*,r*)]-2,3-bis[(4-methylbenzoyl)oxy]succinic Acid
19. (+)-di-p-toluoyl-d-(+)-tartaric Acid
20. Butanedioic Acid, 2,3-bis((4-methylbenzoyl)oxy)-, (2s,3s)-
21. O,o'-di-p-toluoyl-d-tartaric Acid
22. (s(r*,r*))-2,3-bis((4-methylbenzoyl)oxy)succinic Acid
23. Unii-4480ma5qip
24. D-dtta
25. D-ptta
26. (+)-di-o,o'-p-toluyl-d-tartaric Acid
27. Nsc97592
28. Einecs 251-132-2
29. Nsc 97592
30. Di-p-toluoyl-d-tartaricacid
31. Schembl72682
32. Mls001165767
33. (+)-o,o Inverted Exclamation Mark -di-p-toluoyl-d-tartaric Acid
34. Chembl1490343
35. D-(+)-di-p-toluoyltartaric Acid
36. Dtxsid80885539
37. Hms2855f10
38. D-(+)-di-p-toluoyl-tartaric Acid
39. Act02733
40. Str08702
41. Zinc1632794
42. Di-(4-methyl)benzoyl-d-tartaric Acid
43. Akos000278447
44. Rivastigmine Related Compound A
45. Cs-w020568
46. Di-p-toluoyl-d-tartaric Acid Anhydrous
47. Ks-1018
48. (s,s)-o,o'-di-p-toluoyltartaric Acid
49. D-di-o,o'-p-toluyltartaric Acid
50. Ac-13647
51. Smr000550472
52. Sy004755
53. (+)-o,o'-di-1,4-toluoyl-d-tartaric Acid
54. Am20060204
55. D1417
56. D-(+)-tartaric Acid-o,o'-di-p-toluoyl Ester
57. D-bis(o-4-methylbenzoyl)tartaric Acid
58. O,o'-di-p-toluoyl-d-tartaric Acid Anhydrous
59. (2s,3s)-(+)-di-o-4-toluoyl-d-tartaric Acid
60. 34d687
61. Rivastigmine Related Compound A [usp-rs]
62. (2s,3s)-2,3-bis(4-methylbenzoyloxy)succinic Acid
63. O,o'-di-p-toluoyl-d-tartaric Acid, (+)-
64. Q-201014
65. (2s,3s)-2,3-bis[(4-methybenzoyl)oxy]succinic Acid
66. Q27258721
67. Rivastigmine Related Compound A [usp Impurity]
68. (2s,3s)-2,3-bis-(4-methyl-benzoyloxy)-succinic Acid
69. (+)-o,o'-di-p-toluoyl-d-tartaric Acid, Purum, >=98.0%
70. (2s,3s)-(+)-2,3-bis[(4-methylbenzoyl)oxy]butane-1,4-dioic Acid
71. (+)-o,o'-di-p-toluoyl-d-tartaric Acid, Made From Synthetic Tartaric Acid, 97%
72. Rivastigmine Related Compound A, United States Pharmacopeia (usp) Reference Standard
| Molecular Weight | 386.4 g/mol |
|---|---|
| Molecular Formula | C20H18O8 |
| XLogP3 | 3.3 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 9 |
| Exact Mass | 386.10016753 g/mol |
| Monoisotopic Mass | 386.10016753 g/mol |
| Topological Polar Surface Area | 127 Ų |
| Heavy Atom Count | 28 |
| Formal Charge | 0 |
| Complexity | 533 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 2 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
ABOUT THIS PAGE
A Di-P-Toluoyl-D-Tartaric Acid manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Di-P-Toluoyl-D-Tartaric Acid, including repackagers and relabelers. The FDA regulates Di-P-Toluoyl-D-Tartaric Acid manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Di-P-Toluoyl-D-Tartaric Acid API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Di-P-Toluoyl-D-Tartaric Acid manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Di-P-Toluoyl-D-Tartaric Acid supplier is an individual or a company that provides Di-P-Toluoyl-D-Tartaric Acid active pharmaceutical ingredient (API) or Di-P-Toluoyl-D-Tartaric Acid finished formulations upon request. The Di-P-Toluoyl-D-Tartaric Acid suppliers may include Di-P-Toluoyl-D-Tartaric Acid API manufacturers, exporters, distributors and traders.
click here to find a list of Di-P-Toluoyl-D-Tartaric Acid suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Di-P-Toluoyl-D-Tartaric Acid DMF (Drug Master File) is a document detailing the whole manufacturing process of Di-P-Toluoyl-D-Tartaric Acid active pharmaceutical ingredient (API) in detail. Different forms of Di-P-Toluoyl-D-Tartaric Acid DMFs exist exist since differing nations have different regulations, such as Di-P-Toluoyl-D-Tartaric Acid USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Di-P-Toluoyl-D-Tartaric Acid DMF submitted to regulatory agencies in the US is known as a USDMF. Di-P-Toluoyl-D-Tartaric Acid USDMF includes data on Di-P-Toluoyl-D-Tartaric Acid's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Di-P-Toluoyl-D-Tartaric Acid USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Di-P-Toluoyl-D-Tartaric Acid suppliers with USDMF on PharmaCompass.
Di-P-Toluoyl-D-Tartaric Acid Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Di-P-Toluoyl-D-Tartaric Acid GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Di-P-Toluoyl-D-Tartaric Acid GMP manufacturer or Di-P-Toluoyl-D-Tartaric Acid GMP API supplier for your needs.
A Di-P-Toluoyl-D-Tartaric Acid CoA (Certificate of Analysis) is a formal document that attests to Di-P-Toluoyl-D-Tartaric Acid's compliance with Di-P-Toluoyl-D-Tartaric Acid specifications and serves as a tool for batch-level quality control.
Di-P-Toluoyl-D-Tartaric Acid CoA mostly includes findings from lab analyses of a specific batch. For each Di-P-Toluoyl-D-Tartaric Acid CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Di-P-Toluoyl-D-Tartaric Acid may be tested according to a variety of international standards, such as European Pharmacopoeia (Di-P-Toluoyl-D-Tartaric Acid EP), Di-P-Toluoyl-D-Tartaric Acid JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Di-P-Toluoyl-D-Tartaric Acid USP).
LOOKING FOR A SUPPLIER?
